Comparing Adriamycin vs Cisplatin
| Adriamycin Remove Adriamycin from your drug comparison | Cisplatin Remove Cisplatin from your drug comparison |
|---|
| Adriamycin doxorubicin Remove Adriamycin from your drug comparison | Cisplatin Remove Cisplatin from your drug comparison | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Breast Cancer, Bladder Cancer, Acute Lymphoblastic Leukemia, Neuroblastoma, Thyroid Cancer, Stomach Cancer, Soft Tissue Sarcoma, Ovarian Cancer, Osteosarcoma, Lymphoma, Multiple... View more |
Prescribed for Bladder Cancer, Bone Marrow Transplantation, Anal Cancer, Brain Tumor, Blood Cell Transplantation, Cervical Cancer, Neuroblastoma, Non-Small Cell Lung Cancer, Osteogenic Sarcoma,... View more |
|
|||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
Ratings & ReviewsRecent helpful reviews |
|||||||||||||||||
|
6.6
For Breast Cancer: Adriamycin made me really weak and I had to have blood transfusions. I had 4 doses. I'm coming up on 3 years cancer free so I think it worked well. I'm concerned about the long term side effects. |
10.0
|
||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
|
Common side effects include: severe nausea and vomiting, nausea and vomiting, and alopecia. See the full Adriamycin side effects document. |
Commonly reported side effects include: bone marrow depression, nephrotoxicity, and ototoxicity. See the full cisplatin side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Adriamycin prices and generic prices |
View all cisplatin prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
|
Yes (this medicine) |
|||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
| Other doxorubicin brands include: Adriamycin PFS, Adriamycin RDF |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
|
30 hours |
73 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
Drug Interactions |
|||||||||||||||||
|
A total of 476 drugs are known to interact with Adriamycin:
|
A total of 363 drugs are known to interact with cisplatin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
|
N/A |
December 19, 1978 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
|
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
For Breast Cancer: I did not experience any side effects, but based on a clinical trial result, I walked at a brisk pace for an hour most days to avoid cardiotoxicity.